Search results
Results from the WOW.Com Content Network
Monoamine Oxidase Inhibitors (MAOI) Side Effects Compared to newer antidepressants, such as SSRIs and SNRIs, MAOIs are more likely to cause certain side effects and interactions. Side effects of ...
Monoamine oxidase inhibitors (MAOIs). MAOIs are an older class of antidepressants, primarily used in the 20th century. Because of their side effects and interaction risk, most MAOIs have been ...
The knowledge of MAOIs began with the serendipitous discovery that iproniazid was a potent MAO inhibitor (MAOI). [45] Originally intended for the treatment of tuberculosis, in 1952, iproniazid's antidepressant properties were discovered when researchers noted that the depressed patients given iproniazid experienced a relief of their depression.
Pargyline, sold under the brand name Eutonyl among others, is a monoamine oxidase inhibitor (MAOI) medication which has been used to treat hypertension (high blood pressure) but is no longer marketed. [4] [5] [6] It has also been studied as an antidepressant, but was never licensed for use in the treatment of depression. [7] [8] The drug is ...
[13] [7] [19] [2] It is a selective inhibitor of monoamine oxidase B (MAO-B) at lower doses but additionally inhibits monoamine oxidase A (MAO-A) at higher doses. [ 13 ] [ 7 ] [ 19 ] [ 2 ] MAO-B inhibition is thought to result in increased levels of dopamine and β-phenethylamine , whereas MAO-A inhibition results in increased levels of ...
While its half-life is only about 2 hours, its pharmacodynamic effects last several days to weeks due to irreversible inhibition of MAO. [20] Metabolites of tranylcypromine include 4-hydroxytranylcypromine, N-acetyltranylcypromine, and N-acetyl-4-hydroxytranylcypromine, which are less potent MAO inhibitors than tranylcypromine itself. [20]
As a MAO inhibitor, safinamide can theoretically cause hypertensive crises, serotonin syndrome and other severe side effects when combined with other MAO inhibitors or with drugs that are known to interact with MAO inhibitors, such as pethidine, dextromethorphan, selective serotonin reuptake inhibitors (SSRIs), serotonin–noradrenaline ...
Moclobemide is a benzamide, [13] derivative of morpholine, [98] which acts pharmacologically as a selective, reversible inhibitor of monoamine oxidase-A (RIMA), [10] a type of monoamine oxidase inhibitor (MAOI), and increases levels of norepinephrine (noradrenaline), dopamine, and especially serotonin [9] [99] in neuronal cells as well as in ...